Crossmark

Manage cardiovascular risk in patients with type 2 diabetes by using agents with proven cardiovascular benefits

Published Online: 2020-02-24

Published Print: 2020-05

Authors

,
License Information

Text and Data Mining valid from 2020-02-24

Version of Record valid from 2020-02-24
More Information

Article History

First Online: 24 February 2020

Compliance with ethical standards

:

: The authors declare no conflicts of interest.

: The preparation of this review was not supported by any external funding.

Document is current